[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604209":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":12,"collaborators":10,"id":16,"slug":17,"hasResults":18,"nctId":19,"briefTitle":20,"officialTitle":20,"acronym":10,"eligibilityCriteria":21,"healthyVolunteers":18,"sex":22,"minAge":23,"maxAge":10,"enrollmentInfo":24,"targetDuration":10,"studyType":27,"phases":10,"briefSummary":28,"conditions":29,"keywords":32,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"study group",null,"patients with myeloid leukemia",{"type":13,"investigatorFullName":14,"investigatorTitle":15,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Mohamed Hesham Abdel Raheem","Assistant Lecturer","100604209","expression-pattern-and-possible-clinical-significance-of-cd81-in-myeloid-leukemia-100604209",false,"NCT07146542","Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia","Inclusion Criteria:\n\n* 1\\. Myeloid leukemia patients 2. Patients of both genders (Males and females) at any age 3. Cases are de novo (Not on treatment)\n\nExclusion Criteria:\n\n* . Patients with other haematological neoplasms (ALL,CLL, plasma cell myeloma, etc)\n\n  * Patients under any therapeutic intervention\n  * Patients with current or previous other malignancies at time of diagnosis","ALL","18 Years",{"count":25,"type":26},66,"ESTIMATED","OBSERVATIONAL","The goal of this study is to understand how the protein CD81 affects myeloid leukemia (especially AML) and whether it can help predict patient outcomes or guide treatment.\n\nThe main question it aims to answer:\n\nIs high CD81 expression in myeloid leukemia cells linked to more aggressive disease, poorer treatment response, or shorter survival in patients?\n\nParticipants:\n\n* Newly diagnosed myeloid leukemia patients (primary focus on AML)\n* Bone marrow or blood samples will be collected during routine diagnostic procedures",[30,31],"Acute Myeloid Leukemia","Chronic Myeloid Leukemia",[33,34,35,36,37],"CD81","AMl","CML","Myeloid","Leukemia","NOT_YET_RECRUITING","2025-08-21",{"date":41,"type":42},"2025-08-28","ACTUAL",{"date":44,"type":26},"2025-10-01",{"date":46,"type":26},"2028-03",{"name":5,"class":6}]